Events & Presentations

Presentation

Highlighted Events

Upcoming Events

Past Events

Date Event Details
September 14, 2020
11:00 AM EDT
September 11, 2020
12:00 PM EDT
June 23, 2020
1:00 PM EDT
June 18, 2020
1:40 PM EDT
June 3, 2020
10:30 AM EDT
May 28, 2020
10:00 AM PDT
A list of stockholders entitled to vote at the Annual Shareholder Meeting will be available for examination for any purpose germane to the Annual Shareholder Meeting for ten days prior to the Annual Shareholder Meeting. You may email protagonist@troutgroup.com to coordinate arrangements to view the stockholder list.
May 7, 2020
5:00 PM EDT
March 10, 2020
4:30 PM EDT
February 25, 2020
10:30 AM EST
December 5, 2019
1:30 PM EST
December 3, 2019
8:30 AM EST
November 20, 2019
2:25 PM EST
October 2, 2019
2:25 PM EDT
September 10, 2019
9:10 AM EDT
June 25, 2019
3:40 PM EDT
June 7, 2019
10:00 AM PDT
101 California Street,
Fifth Floor,
San Francisco, CA 94010
May 18 - May 21, 2019
Title: The Oral α4β7 Integrin Specific Antagonist PN-10943 is More Effective Than PTG 100 in Multiple Preclinical Studies
Presenting Author: Larry Mattheakis, PhD, Sr. VP, Discovery Biology and Translational Research
 
May 8, 2019
8:30 AM EDT
April 9, 2019
9:50 a.m. BST
March 12, 2019
4:30 PM EDT
February 28, 2019
9:00 AM EST
December 12, 2018
9:20 AM EST
November 27, 2018
4:30 PM EST
October 20, 2018 12:00 PM EDT through
October 24, 2018 11:59 PM EDT

Presentation Title: PTG-100, an oral gut-restricted peptide alpha-4-beta-7 antagonist induces clinical and histologic remission in patients with moderate to severely active ulcerative colitis
Date and Time: Monday, October 22 from 14:00 to 15:30 CEST
Session: Room C – Clinical trials in IBD
Location: ACV, Vienna, Austria

September 24, 2018
7:00 AM EDT
Event date, time and location: October 1, 2018 at 4:40 PM EDT at the InterContinental New York Barclay Hotel
August 6, 2018
8:00 AM EDT
June 20, 2018
2:00 PM EDT
June 14, 2018 12:00 PM CEST through
June 17, 2018 11:59 PM CEST
Presentation Title: Hepcidin mimetic PTG-300 for treatment of ineffective erythropoiesis and chronic anemia in hemoglobinopathy diseases
Date and Time: Saturday, June 16 from 11:45 AM to 12:00 PM CEST
Session: Thalassemias
Location: Stockholm International Fairs Convention Center, Room K2

Presentation Title: Hepcidin Mimetic PTG-300 induces dose-related and sustained reductions in serum iron and transferrin saturation in healthy subjects
Date and Time: Saturday, June 16 from 5:00 PM to 5:15 PM CEST
Session: Iron metabolism, deficiency and overload
Location: Stockholm International Fairs Convention Center, Room A13
Stockholm, Sweden

Stockholm International Fairs
125 30 Stockholm
Sweden

June 2, 2018
12:00 PM EDT
Presentation Title: Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-D
Date and Time: Saturday, June 2 from 5:00 PM to 5:15 PM ET
Session: Diarrhea and Irritable Bowel Syndrome - New Advances
Location: Washington Convention Center, Room 140
Presenting author: Larry Mattheakis, Vice President of Biology, Protagonist Therapeutics, Inc.
Walter E. Washington Convention Center in Washington, D.C.

United States

May 29, 2018
11:00 AM PDT
Conference Center
Pacific Research Center
7677 Gateway Blvd.
Newark, California 94560
March 26, 2018
8:00 AM EDT
March 21, 2018
3:20 PM EDT
The Westin New York Grand Central hotel in New York, NY

United States

March 15, 2018
11:15 AM EDT
March 7, 2018
4:30 PM EST
February 26 - March 2, 2018

Location:

Snowbird, UT
United States

February 14, 2018
9:30 AM EST
Lotte New York Palace in New York, NY

United States

December 14, 2017
8:00 AM EST
Westin Grand Central Hotel, New York, NY

United States

November 15, 2017
10:15 AM EST
Lotte New York Palace Hotel in New York, NY

United States

September 26, 2017
8:35 AM EDT
InterContinental New York Barclay Hotel

New York, NY
United States

May 30, 2017
8:00 AM EDT
Event date and time: May 30, 2017 at 8:00 AM EDT
Webcast link: http://edge.media-server.com/m/p/bbh32fun
Teleconference details: toll-free 844-515-9178 or toll call +1-614-999-9313, conference ID number 30341699
May 25, 2017
10:00 AM PDT
Conference Center
Pacific Research Center
7677 Gateway Blvd.
Newark, CA 94560
May 6, 2017 12:00 PM EDT through
May 9, 2017 11:59 PM EDT
Presentation Title: The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Tracks with Efficacy in a Preclinical Model of IBD
Date and Time: Saturday, May 6 from 11:15 AM to 11:30 AM CT
Location: McCormick Place, Room S102d
Chicago, Illinois

United States

April 24, 2017 12:00 PM EDT through
April 25, 2017 11:59 PM EDT
Session: Advances in Peptide Therapeutics
Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, in Clinical Development for the Treatment of Inflammatory Bowel Disease
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics
Date and Time: 9-9:30 AM BST, Tuesday April 25
Room: Conference Room 3- Epernay
London, UK, Novotel London West

United States

April 23, 2017 12:00 PM EDT through
April 27, 2017 11:59 PM EDT

Presentation: Biomarker Discovery and Development of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor
Meeting: 8th Annual Inflammation Inhibitors: Small Molecule Approaches for Oral-based Therapeutics
Presenter: Larry Mattheakis, Ph.D., Vice President, Biology, Protagonist Therapeutics Date and Time: 10:35 am PT, Monday April 24

Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, for the Treatment of Inflammatory Bowel Disease
Meeting: 5th Annual Macrocyclics and Constrained Peptides: Bigger, Better and Still Oral Small Molecules
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics Date and Time: 2:20 PM PT, Wednesday April 26

San Diego, CA, Sheraton San Diego Hotel and Marina

United States

March 21, 2017
2:10 PM EDT
Westin New York Grand Central hotel, New York, NY.

United States

March 14, 2017
2:05 PM EDT
Presenting: Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer
Miami, FL, Loews Miami Beach Hotel

United States

February 16, 2017
11:00 AM EST
Presenting: Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer
New York, NY, Lotte New York Palace

United States

February 15, 2017 12:00 PM EST through
February 18, 2017 11:59 PM EST
Poster Number: P113
Poster Title: Model based predictions of the PTG-100 pharmacodynamic responses in Ulcerative Colitis patients
Date and Time: February 17, 2017 12:30-13:30
Presenting Author: Larry Mattheakis


Poster Number: P001
Poster Title: The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Tracks with Efficacy in a Preclinical Model of IBD
Date and Time: February 17, 2017 12:30-13:30
Presenting Author: Lili Cheng
Barcelona, Spain

United States

December 14, 2016
2:20 PM EST

New York, NY
United States

December 8, 2016 12:00 PM EST through
December 9, 2016 11:59 PM EST
Poster Number: P-271
Poster Title: The Biomarker Profile of PTG-200, An Oral Peptide Antagonist of IL-23 Receptor, Correlates with Efficacy in Preclinical Models of IBD
Date and Time: Friday, December 9, 2016 06:00 PM - 07:00 PM ET
Poster Location: Exhibit Hall - Atlantic B-C

Orlando, FL
United States

November 7, 2016 12:00 PM EST through
November 9, 2016 11:59 PM EST
Cologne Germany

United States

October 15, 2016 12:00 PM EDT through
October 19, 2016 11:59 PM EDT
Poster Number: P0298
Poster Title: Safety, Pharmacokinetics and Pharmacodynamics of the Novel Oral Peptide Therapeutic PTG-100 (alpha4-beta7 Integrin Antagonist) in Normal Healthy Volunteers
Date and Time: Monday October 17, 10:30 - 17:00, presentation 12:30 - 13:30 CET
Presenting Author: Richard S. Shames, MD, Protagonist Chief Medical Officer


Poster Number: P0792
Poster Title: Pharmacokinetics and Pharmacodynamics Following Oral Administration of PTG-100, a Peptide Antagonist of Integrin alpha4-beta7
Date and Time: Tuesday October 18, 9:00 to 17:00, presentation 12:30 - 13:30 CET
Presenting Author: Thamil Annamalai, M.S., Protagonist Senior Director, Preclinical Development
Vienna Austria

United States

August 23, 2016
10:00 AM EDT
Philadelphia, PA

United States